BioMarin Pharma (BMRN) Tops Q1 EPS by 43c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $57.35 +0.03%
EPS Growth %: -34.0%
Financial Fact:
Total revenues: 279.9M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -34.0%
Financial Fact:
Total revenues: 279.9M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of $1.13, $0.43 better than the analyst estimate of $0.70. Revenue for the quarter came in at $745 million versus the consensus estimate of $741.02 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Outdoor Brands (AOUT) Tops Q4 EPS by 14c
- Trump Administration Asks OpenAI to Stagger Release of New Model Over Security Concerns - Information
- Aurania closes C$1.26M private placement in two tranches
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
